Japan Cancer Biopsy Market was valued at USD 0.80 Billion in 2022 and is projected to reach USD 1.30 Billion by 2030, growing at a CAGR of 6.80% from 2024 to 2030.
The Japan Cancer Biopsy Market is witnessing rapid growth due to the increasing prevalence of cancer cases and the rising demand for early diagnosis and personalized treatment. Biopsy, being one of the most essential diagnostic tools for cancer, has become crucial in detecting and understanding various types of cancer. With advancements in technology, the biopsy market in Japan has diversified, introducing various types that cater to different types of cancer and specific patient needs. Among these, liquid biopsy and core needle biopsy are growing in demand due to their minimal invasiveness and enhanced accuracy.
Liquid biopsy, in particular, has garnered significant attention in recent years. It offers a non-invasive way to detect cancerous cells or genetic mutations in a patient's blood, making it an attractive option for both patients and healthcare providers. This method is considered a breakthrough, especially for cancers like lung, breast, and colorectal cancer, which have seen significant improvements in survival rates due to early detection. With the global shift towards minimally invasive procedures, the demand for such biopsy techniques has escalated in Japan’s cancer treatment market.
Another market segment gaining traction is the rise in core needle biopsies, which provide highly accurate tissue samples for diagnostic purposes. The development of advanced imaging techniques like ultrasound and MRI has further enhanced the precision of these procedures. In the context of Japan’s aging population, these innovations offer the promise of better diagnostic accuracy and reduced patient recovery time, further driving market demand.
Industries within Japan, especially those in healthcare and pharmaceuticals, are increasingly focused on the need for precise diagnostic tools. Companies in these sectors are investing heavily in research and development to improve biopsy techniques and enhance the reliability of results. The growing demand for personalized medicine has spurred the need for biopsy methods that can provide not only cancer detection but also genetic insights that can guide treatment options.
Additionally, the market's growth is being fueled by technological advancements in biopsy tools and a surge in the number of cancer diagnostic centers across Japan. The need for efficient, accurate, and affordable biopsy solutions has never been greater, as healthcare professionals seek to provide the best outcomes for patients battling cancer. As Japan continues to prioritize healthcare innovation, the cancer biopsy market is set to expand, driven by the ongoing need for effective diagnostics and treatment plans.
Get an In-Depth Research Analysis of the Japan Cancer Biopsy Market Size And Forecast [2025-2032]
Qiagen N.V.
Illumina
Inc
ANGLE Plc
Myriad Genetics
Hologic
Inc
Biocept
Inc
Thermo Fisher Scientific
Inc
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL
Inc
Guardant Health
Exact Sciences Corporation
Freenome Holdings
Inc
Oncimmune
Chronix Biomedical
Inc
Personal Genome Diagnostics Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Cancer Biopsy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Cancer Biopsy Market
Needle Biopsy
Excisional Biopsy
Incisional Biopsy
Endoscopic Biopsy
Fine-Needle Aspiration Biopsy (FNAB)
Imaging-guided Biopsy
Optical Biopsy
Molecular Biopsy
Liquid Biopsy
Electromagnetic Navigation Biopsy
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Gynecological Cancer
Hospitals
Diagnostic Laboratories
Research Institutions
Specialty Clinics
Ambulatory Surgical Centers
Tissue Samples
Blood Samples
Saliva Samples
Urinary Samples
Bone Marrow Samples
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Japan Cancer Biopsy Market Research Analysis
1. Introduction of the Japan Cancer Biopsy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Cancer Biopsy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Cancer Biopsy Market, By Type
6. Japan Cancer Biopsy Market, By Application
7. Japan Cancer Biopsy Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. Japan Cancer Biopsy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/